APA aipamena

Zerbini, C. A., Abud-Mendoza, C., Mendez-Patarroyo, P., De Angelo Andrade, M., Pedersen, R., Vlahos, B., & Borlenghi, C. E. (2018). Maintenance of low disease activity and remission with etanercept–disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis: Subset analysis of a randomized trial. Medicine (Baltimore).

Chicago Style aipamena

Zerbini, Cristiano A.F., Carlos Abud-Mendoza, Paul Mendez-Patarroyo, Mauricio De Angelo Andrade, Ron Pedersen, Bonnie Vlahos, and Cecilia Elena Borlenghi. "Maintenance of Low Disease Activity and Remission With Etanercept–disease-modifying Antirheumatic Drug (DMARD) Combination Therapy Compared With Treatment With DMARDs Alone in Latin American Patients With Active Rheumatoid Arthritis: Subset Analysis of a Randomized Trial." Medicine (Baltimore) 2018.

MLA aipamena

Zerbini, Cristiano A.F., et al. "Maintenance of Low Disease Activity and Remission With Etanercept–disease-modifying Antirheumatic Drug (DMARD) Combination Therapy Compared With Treatment With DMARDs Alone in Latin American Patients With Active Rheumatoid Arthritis: Subset Analysis of a Randomized Trial." Medicine (Baltimore) 2018.